• 1. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 5. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to 5-Aminolevulinic Acid Hydrochloride (CAS No. 5451-09-2)

5-Aminolevulinic acid hydrochloride, with the chemical identifier CAS No. 5451-09-2, is a compound of significant interest in the field of pharmaceutical chemistry and biotechnology. This compound, commonly known as hydrochloride salt of 5-aminolevulinic acid (5-ALA-HCl), has garnered considerable attention due to its multifaceted applications, particularly in medical imaging and photodynamic therapy (PDT). The unique structural and chemical properties of this molecule have positioned it as a cornerstone in the development of novel therapeutic strategies.

The molecular structure of 5-Aminolevulinic acid hydrochloride consists of a levulinic acid backbone substituted with an amino group at the 5-position. This configuration imparts a high degree of reactivity, making it an ideal precursor in the biosynthetic pathway of heme, a critical component of hemoglobin and other hemoproteins. The hydrochloride form enhances its solubility, facilitating its use in aqueous solutions for medical applications.

In recent years, 5-Aminolevulinic acid hydrochloride has been extensively studied for its potential in tumor-targeted imaging and therapy. One of the most notable advancements in this field is its use in fluorescence-guided surgery. When administered intravenously or topically, 5-ALA is preferentially accumulated in rapidly dividing cells, such as those found in malignant tumors. Under exposure to specific wavelengths of light, typically in the range of 405-635 nm, the compound undergoes oxidation to form a fluorescent porphyrin derivative. This fluorescence can be detected using specialized imaging equipment, allowing surgeons to identify and remove cancerous tissues with high precision.

Moreover, the phototoxic properties of 5-Aminolevulinic acid hydrochloride have been leveraged in photodynamic therapy (PDT) for treating various malignancies and non-malignant conditions. PDT involves the administration of a photosensitizer, such as 5-ALA derivatives, followed by localized exposure to light. The light activates the photosensitizer, generating reactive oxygen species (ROS) that induce apoptosis or necrosis in target cells. Recent clinical trials have demonstrated promising results in using 5-ALA-PDT for superficial cancers, including actinic keratosis and basal cell carcinoma.

The versatility of 5-Aminolevulinic acid hydrochloride extends beyond oncology. Emerging research indicates its potential in treating infectious diseases and inflammatory conditions. For instance, studies have shown that 5-ALA can enhance the efficacy of certain antimicrobial agents by inducing oxidative stress in bacterial cells. Additionally, its ability to modulate immune responses has sparked interest in its application for inflammatory bowel disease and other autoimmune disorders.

From a synthetic chemistry perspective, 5-Aminolevulinic acid hydrochloride serves as a valuable intermediate in the production of various porphyrin-based compounds. These derivatives find applications not only in medicine but also in materials science and environmental technology. For example, porphyrins are being explored as catalysts for water splitting and carbon dioxide reduction, contributing to sustainable energy solutions.

The regulatory landscape for 5-Aminolevulinic acid hydrochloride varies by region but generally requires rigorous testing to ensure safety and efficacy before clinical use. In the United States, the Food and Drug Administration (FDA) has approved its use for acne treatment under brand names like Levulan? Kerastick? and Levulan? Gel?. In Europe, regulatory bodies such as the European Medicines Agency (EMA) have similarly sanctioned its application in dermatological procedures.

Future research directions for 5-Aminolevulinic acid hydrochloride include optimizing delivery systems to enhance tumor specificity and minimizing side effects associated with PDT. Advances in nanotechnology have led to the development of nanoparticles capable of targeted drug delivery, improving therapeutic outcomes while reducing systemic toxicity. Additionally, combining 5-ALA with other treatments, such as immunotherapy or chemotherapy, may yield synergistic effects that surpass single-agent therapies.

The growing body of evidence supporting the therapeutic potential of 5-Aminolevulinic acid hydrochloride underscores its importance as a pharmaceutical compound. As research continues to uncover new applications and refine existing ones, this molecule is poised to play an increasingly significant role in modern medicine.

• 90251-19-7(Nonanoic acid, 9-amino-8-oxo-, hydrochloride)
• 168689-41-6(Octanoic acid, 8-amino-7-oxo-, hydrochloride (1:1))
• 89102-41-0(2-Decanone, 1-amino-10-hydroxy-, hydrochloride)
• 177408-65-0(8-Amino-7-oxopelargonic Acid Hydrochloride)
• 62409-52-3(Hexanoic acid, 6-amino-5-oxo-, hydrochloride)
• 187237-35-0(Pentanoic-2,2-d2 acid,5-amino-4-oxo-, hydrochloride (9CI))
• 177408-66-1((S)-8-Amino-7-oxononanoic acid hydrochloride)
• 4707-58-8(8-Amino-7-oxononanoic acid)
• 106-60-5(5-Amino-4-oxopentanoic acid)
• 116571-80-3(5-Amino-15N-levulinic Acid Hydrochloride)